Signal Detection of Adverse Drug Reactions of Cephalosporins Using Data from a National Pharmacovigilance Database
This case-non-case study aims to detect signals not currently listed on cephalosporin drug labels. From 2009 to 2018, adverse event (AE) reports concerning antibacterial drugs (anatomical therapeutic chemical (ATC) code J01) in the Korea Adverse Events Reporting System (KAERS) database were examined...
Saved in:
Main Authors: | Jung-Yoon Choi (Author), Jae-Hee Choi (Author), Myeong-Gyu Kim (Author), Sandy-Jeong Rhie (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Major Aspects of Detection and Monitoring of Adverse Reactions Associated with Cephalosporin Antibiotic Treatment
by: E. Yu. Demchenkova, et al.
Published: (2021) -
Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database
by: Rosanna Ruggiero, et al.
Published: (2020) -
Serious Safety Signals and Prediction Features Following COVID-19 mRNA Vaccines Using the Vaccine Adverse Event Reporting System
by: Jung Yoon Choi, et al.
Published: (2024) -
Hypothesis-free signal detection in healthcare databases: finding its value for pharmacovigilance
by: Andrew Bate, et al.
Published: (2019) -
Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database
by: Maria Antonietta Barbieri, et al.
Published: (2022)